scorecardresearchSanofi India Share Price Live NSE, BSE, Today - Sanofi India Stock Price
Mintgenie
Asian Paints3,233.150
Axis Bank1,116.85-14.25 (-1.26%)
Bajaj Finance7,290.00-16.85 (-0.23%)
Bajaj Finserve1,702.95-7.30 (-0.43%)
Bharti Airtel997.45-2.05 (-0.21%)
HCL Technologies1,374.0011.10 (0.81%)
HDFC Bank1,650.75-2.35 (-0.14%)
Hindustan Unilever2,504.45-16.90 (-0.67%)
ICICI Bank1,017.056.10 (0.60%)
ITC452.303.15 (0.70%)
Indusind Bank1,521.5012.35 (0.82%)
Infosys1,488.60-2.00 (-0.13%)
Kotak Mahindra Bank1,843.956.60 (0.36%)
Larsen & Toubro3,384.505.75 (0.17%)
Mahindra & Mahindra1,652.00-16.60 (-0.99%)
Maruti Suzuki India10,538.35-62.55 (-0.59%)
NTPC287.352.10 (0.74%)
Nestle India25,110.00321.70 (1.30%)
Power Grid Corporation Of India230.952.40 (1.05%)
Reliance Industries2,459.052.85 (0.12%)
State Bank Of India614.350.35 (0.06%)
Sun Pharmaceutical Industries1,235.700.20 (0.02%)
Tata Consultancy Services3,642.2015.80 (0.44%)
Tata Motors720.756.10 (0.85%)
Tata Steel130.050.85 (0.66%)
Tech Mahindra1,232.907.25 (0.59%)
Titan Company3,630.90-3.80 (-0.10%)
Ultratech Cement9,685.00285.35 (3.04%)
Wipro420.35-1.65 (-0.39%)

Sanofi India

BSE: 500674 | NSE: SANOFI | ISIN: INE058A01010 | SECTOR: Biotechnology & Drugs

₹8,182.35 46.40 (0.57%)

11 Dec 2023, 09:59 (IST)

  • Open

    8,165.00

  • High

    8,205.00

  • Low

    8,058.50

  • Prev Close

    8,135.95

  • P/E

    -

  • Median P/E

    -

  • P/B

    -

  • Median P/B

    -

  • Market Cap

    188.44B

  • Volume

    0.66K

  • Vol. (20 day Avg.)

    0

  • PEG

    -

  • Div.Yield

    -

  • Bid

    -

  • Ask

    -
View all metrics

Company Description

  • Biotechnology & Drugs

  • BSE

    500674

  • NSE

    SANOFI

  • ISIN

    INE058A01010

Sanofi India Limited is a healthcare company. The Company is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals. It offers a range of medicines and supplements for treatment of diabetes (both insulin and orals), cardiology, thrombosis, epilepsy, allergies, and infections. It has two manufacturing sites, one in Hyderabad and one in Goa. Its geographical segments include India, Singapore, and Others. It sells its products through independent distributors primarily in India. It also manufactures its products through third party manufacturers. The different types of dosage forms include tablets, capsules (hard and soft), eye/ear drops, ampoules, vials, creams, and ointment. Its brands include Lantus, Allegra, and Combiflam. Its vaccine products include Adacel, Avaxim 80U/160U, FluQuadri, Hexaxim, Menactra, Tetraxim, Vaxigrip, Stamaril, Shanvac-B and ShanTT. Its consumer healthcare products include Allegra, Allegra nasal, and Avil.

Company Officers

  • Rachid Ayari

    Chief Financial Officer, Whole-time Director

  • Radhika Shah

    Compliance Officer, Company Secretary

  • Rodolfo Hrosz

    Managing Director, Whole Time Director

  • Renee Amonkar

    Additional Whole Time Director

  • Bratin Bag

    Senior Director - Ethics and Business Integrity, South Asia

  • Surabhi Kaul

    India People Director

  • Shalini Menon

    General Medicines Medical Head - India, India Medical Lead

  • Yasmin Shenoy

    Senior Director - Regulatory Affairs

  • Aparna Thomas

    Senior Director - Corporate Communications and Corporate Social Responsibility, India and South Asia

  • Linumon Thomas

    Digital Leader, India